Amyloid pterygium of eye, bilateral
ICD-10 H11.013 is a billable code used to indicate a diagnosis of amyloid pterygium of eye, bilateral.
Amyloid pterygium of the eye, bilateral, is characterized by the deposition of amyloid protein in the conjunctiva, leading to a yellowish-white, gelatinous appearance. This condition typically affects the conjunctiva but can also involve the sclera and cornea, potentially causing visual disturbances. The bilateral nature of this condition suggests systemic amyloidosis, which may be associated with underlying diseases such as multiple myeloma or chronic inflammatory conditions. Clinically, patients may present with irritation, discomfort, or cosmetic concerns. The disease progression can vary; while some patients remain asymptomatic, others may experience significant ocular surface issues. Diagnostic considerations include a thorough ocular examination, slit-lamp evaluation, and possibly a biopsy to confirm amyloid deposits. The presence of amyloid pterygium may necessitate further investigation for systemic conditions, emphasizing the importance of a comprehensive clinical assessment.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
H11.013 specifically covers bilateral amyloid pterygium, which is characterized by amyloid deposits in the conjunctiva. It is important to differentiate this from other conjunctival lesions such as pterygium or conjunctival cysts.
H11.013 should be used when there is confirmed bilateral amyloid pterygium, especially when systemic evaluation for amyloidosis is warranted. It is distinct from unilateral cases or other conjunctival disorders.
Documentation should include a detailed ocular examination, findings from slit-lamp evaluation, and any biopsy results confirming amyloid deposits. Notes on systemic evaluation for underlying conditions are also crucial.
